Technology | May 15, 2015

McKesson Offers iPad App to Review Cancer Protocols, Guidelines

Application highlights evidence-based treatment options at the point of care

McKesson Specialty Health, Guideline Explorer, cancer, iPad, Clear Value Plus

May 15, 2015 — McKesson Specialty Health announced the availability of Clear Value Plus – Guideline Explorer to iPad users. The Guideline Explorer app is a mobile reference tool that gives users access to evidence-based cancer protocols based on patient attributes.

Available for download on the Apple App Store at no cost, the Guideline Explorer app provides users with an easy-to-use interface for exploring patient-specific treatment options based on the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) and Value Pathways powered by NCCN. Current Clear Value Plus users can access the complete range of evidence-based treatment options and see all treatment choices that are highlighted as part of the Value Pathways powered by NCCN. New iPad users can navigate NCCN Content and explore chemotherapy regimens based on specific patient characteristics and quickly view up-to-date chemotherapy options, as well as known side effect profiles.

The new iPad tool is an extension of McKesson Specialty Health’s Clear Value Plus, a quality support tool for oncologists that highlights evidence-based treatment options at the point of care. The software brings to life Value Pathways powered by NCCN and NCCN Guidelines within the clinical workflow—offering evidence-based protocols at the point of care with the patient. In addition, Clear Value Plus is compatible with multiple provider systems and provides integrated financial information, real-time reporting and benchmarking to demonstrate the value of delivering evidence-based care.

For more information: www.mckessonspecialtyhealth.com

Related Content

News | Radiation Therapy | May 06, 2021
May 6, 2021 — Individuals living with severe...
Research finds that a commonly used risk-prediction model for lung cancer does not accurately identify high-risk Black patients who could benefit from early screening

Getty Images

News | Lung Imaging | May 05, 2021
May 5, 2021 — Lung cancer is the third most common cance
The emergence of #therapeutic #radiopharmaceuticals and its adoption in #cancer care provide one more weapon in combating cancer

Getty Images

Feature | Radiation Oncology | May 04, 2021 | By Vinay Shivaprasad
The term nuclear medicine is associated with the diag
A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | May 03, 2021 | By Dave Fornell, Editor
While the mass COVID-19 vaccinat
Despite receiving high radiation doses to their tumors, lung cancer patients treated with technique that spares a large part of the esophagus did not develop severe inflammation of the esophagus

Getty Images

News | Lung Imaging | April 30, 2021
April 30, 2021 — For many patients with localized lung cance...
#prostatecancer During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate cancer in Sweden than in previous years.

Getty Images

News | Prostate Cancer | April 30, 2021
April 30, 2021 — During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate canc
ACR releases 13 new topics and five revised topics to support referring physicians and other providers in making the most appropriate imaging or treatment decisions
News | Radiology Imaging | April 26, 2021
April 26, 2021 — The American College of Radiology (ACR) released an update to its...
A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects of stereotactic body radiotherapy for treating multiple metastases has determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases.

Image courtesy of Accuray

News | Stereotactic Body Radiation Therapy (SBRT) | April 23, 2021
April 23, 2021 — A phase 1 clinical trial led by investigators at the...
A Norwegian study for the first time reveals benefit of the #PARP inhibitor #Olaparib in patients with early #breastcancer not harboring germline mutations

Getty Images

News | Radiation Therapy | April 22, 2021
April 22, 2021 — Targeted therapy in early stages of breas...